Suppr超能文献

磁共振成像和中文嗅觉识别测试揭示轻度认知障碍和阿尔茨海默病中气味识别的脑结构相关性

Brain Structural Correlates of Odor Identification in Mild Cognitive Impairment and Alzheimer's Disease Revealed by Magnetic Resonance Imaging and a Chinese Olfactory Identification Test.

作者信息

Wu Xingqi, Geng Zhi, Zhou Shanshan, Bai Tongjian, Wei Ling, Ji Gong-Jun, Zhu Wanqiu, Yu Yongqiang, Tian Yanghua, Wang Kai

机构信息

Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, China.

出版信息

Front Neurosci. 2019 Aug 14;13:842. doi: 10.3389/fnins.2019.00842. eCollection 2019.

Abstract

Alzheimer's disease (AD) is a common memory-impairment disorder frequently accompanied by olfactory identification (OI) impairments. In fact, OI is a valuable marker for distinguishing AD from normal age-related cognitive impairment and may predict the risk of mild cognitive impairment (MCI)-to-AD transition. However, current olfactory tests were developed based on Western social and cultural conditions, and are not very suitable for Chinese patients. Moreover, the neural substrate of OI in AD is still unknown. The present study investigated the utility of a newly developed Chinese smell identification test (CSIT) for OI assessment in Chinese AD and MCI patients. We then performed a correlation analysis of gray matter volume (GMV) at the voxel and region-of-interest (ROI) levels to reveal the neural substrates of OI in AD. Thirty-seven AD, 27 MCI, and 30 normal controls (NCs) completed the CSIT and MRI scans. Patients (combined AD plus MCI) scored significantly lower on the CSIT compared to NCs [(2,91) = 62.597, < 0.001)]. Voxel-level GMV analysis revealed strong relationships between CSIT score and volumes of the left precentral gyrus and left inferior frontal gyrus (L-IFG). In addition, ROI-level GMV analysis revealed associations between CSIT score and left amygdala volumes. Our results suggest the following: (1) OI, as measured by the CSIT, is impaired in AD and MCI patients compared with healthy controls in the Chinese population; (2) the severity of OI dysfunction can distinguish patients with cognitive impairment from controls and AD from MCI patients; and (3) the left-precentral cortex and L-IFG may be involved in the processing of olfactory cues.

摘要

阿尔茨海默病(AD)是一种常见的记忆障碍疾病,常伴有嗅觉识别(OI)障碍。事实上,OI是区分AD与正常年龄相关认知障碍的重要指标,且可能预测轻度认知障碍(MCI)向AD转化的风险。然而,目前的嗅觉测试是基于西方社会和文化背景开发的,不太适合中国患者。此外,AD中OI的神经基础仍不清楚。本研究调查了一种新开发的中国嗅觉识别测试(CSIT)在中国AD和MCI患者OI评估中的效用。然后,我们在体素和感兴趣区域(ROI)水平上对灰质体积(GMV)进行相关性分析,以揭示AD中OI的神经基础。37名AD患者、27名MCI患者和30名正常对照(NC)完成了CSIT和MRI扫描。患者(AD加MCI合并组)在CSIT上的得分显著低于NC组[(2,91)=62.597,<0.001]。体素水平的GMV分析显示,CSIT得分与左侧中央前回和左侧额下回(L-IFG)体积之间存在密切关系。此外,ROI水平的GMV分析显示,CSIT得分与左侧杏仁核体积之间存在关联。我们的结果表明:(1)在中国人群中,与健康对照相比,AD和MCI患者通过CSIT测量的OI受损;(2)OI功能障碍的严重程度可区分认知障碍患者与对照,以及AD与MCI患者;(3)左侧中央前皮质和L-IFG可能参与嗅觉线索的处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7781/6702423/15019bb2d5d1/fnins-13-00842-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验